200 related articles for article (PubMed ID: 34899293)
1. Untargeted and Targeted Metabolomics Reveal the Underlying Mechanism of Aspirin Eugenol Ester Ameliorating Rat Hyperlipidemia
Xiao-Rong L; Ning M; Xi-Wang L; Shi-Hong L; Zhe Q; Li-Xia B; Ya-Jun Y; Jian-Yong L
Front Pharmacol; 2021; 12():733789. PubMed ID: 34899293
[TBL] [Abstract][Full Text] [Related]
2. Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
Ma N; Liu X; Kong X; Li S; Jiao Z; Qin Z; Dong P; Yang Y; Li J
Lipids Health Dis; 2017 Dec; 16(1):240. PubMed ID: 29228968
[TBL] [Abstract][Full Text] [Related]
3. UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.
Ma N; Karam I; Liu XW; Kong XJ; Qin Z; Li SH; Jiao ZH; Dong PC; Yang YJ; Li JY
Toxicol Appl Pharmacol; 2017 Oct; 332():40-51. PubMed ID: 28733207
[TBL] [Abstract][Full Text] [Related]
4. Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia.
Ma N; Liu XW; Kong XJ; Li SH; Jiao ZH; Qin Z; Yang YJ; Li JY
BMC Vet Res; 2018 Dec; 14(1):405. PubMed ID: 30563510
[TBL] [Abstract][Full Text] [Related]
5. Untargeted lipidomics and metagenomics reveal the mechanism of aspirin eugenol ester relieving hyperlipidemia in ApoE-/- mice.
Lu XR; Liu XW; Li SH; Qin Z; Bai LX; Ge WB; Li JY; Yang YJ
Front Nutr; 2022; 9():1030528. PubMed ID: 36618709
[TBL] [Abstract][Full Text] [Related]
6. A combined transcriptomics and proteomics approach to reveal the mechanism of AEE relieving hyperlipidemia in ApoE
Lu XR; Tao Q; Qin Z; Liu XW; Li SH; Bai LX; Ge WB; Liu YX; Li JY; Yang YJ
Biomed Pharmacother; 2024 Apr; 173():116400. PubMed ID: 38484560
[TBL] [Abstract][Full Text] [Related]
7. Cellular Metabolomics Reveal the Mechanism Underlying the Anti-Atherosclerotic Effects of Aspirin Eugenol Ester on Vascular Endothelial Dysfunction.
Huang MZ; Lu XR; Yang YJ; Liu XW; Qin Z; Li JY
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31261711
[TBL] [Abstract][Full Text] [Related]
8. UPLC-Q-TOF/MS-Based Plasma Metabolomics to Evaluate the Effects of Aspirin Eugenol Ester on Blood Stasis in Rats.
Shen D; Ma N; Yang Y; Liu X; Qin Z; Li S; Jiao Z; Kong X; Li J
Molecules; 2019 Jun; 24(13):. PubMed ID: 31252591
[TBL] [Abstract][Full Text] [Related]
9. Plasma metabonomics and proteomics studies on the anti-thrombosis mechanism of aspirin eugenol ester in rat tail thrombosis model.
Ma N; Yang Y; Liu X; Li S; Qin Z; Li J
J Proteomics; 2020 Mar; 215():103631. PubMed ID: 31891783
[TBL] [Abstract][Full Text] [Related]
10. Multi-Omics Approaches for Liver Reveal the Thromboprophylaxis Mechanism of Aspirin Eugenol Ester in Rat Thrombosis Model.
Tao Q; Ma N; Fan L; Ge W; Zhang Z; Liu X; Li J; Yang Y
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396823
[TBL] [Abstract][Full Text] [Related]
11. FXR agonist GW4064 improves liver and intestinal pathology and alters bile acid metabolism in rats undergoing small intestinal resection.
Cao Y; Xiao Y; Zhou K; Yan J; Wang P; Yan W; Cai W
Am J Physiol Gastrointest Liver Physiol; 2019 Aug; 317(2):G108-G115. PubMed ID: 30920307
[TBL] [Abstract][Full Text] [Related]
12. Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet.
Karam I; Ma N; Liu XW; Kong XJ; Zhao XL; Yang YJ; Li JY
Lipids Health Dis; 2016 Nov; 15(1):196. PubMed ID: 27855711
[TBL] [Abstract][Full Text] [Related]
13. Lactoferrin promotes bile acid metabolism and reduces hepatic cholesterol deposition by inhibiting the farnesoid X receptor (FXR)-mediated enterohepatic axis.
Ling CJ; Xu JY; Li YH; Tong X; Yang HH; Yang J; Yuan LX; Qin LQ
Food Funct; 2019 Nov; 10(11):7299-7307. PubMed ID: 31626262
[TBL] [Abstract][Full Text] [Related]
14. UPLC-Q-TOF/MS-based metabonomic studies on the intervention effects of aspirin eugenol ester in atherosclerosis hamsters.
Ma N; Yang Y; Liu X; Kong X; Li S; Qin Z; Jiao Z; Li J
Sci Rep; 2017 Sep; 7(1):10544. PubMed ID: 28874840
[TBL] [Abstract][Full Text] [Related]
15. Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.
Karam I; Ma N; Liu XW; Li SH; Kong XJ; Li JY; Yang YJ
BMC Vet Res; 2015 Aug; 11():217. PubMed ID: 26289078
[TBL] [Abstract][Full Text] [Related]
16. Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.
Qi Y; Jiang C; Cheng J; Krausz KW; Li T; Ferrell JM; Gonzalez FJ; Chiang JY
Biochim Biophys Acta; 2015 Jan; 1851(1):19-29. PubMed ID: 24796972
[TBL] [Abstract][Full Text] [Related]
17. Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice.
Fu ZD; Cui JY; Klaassen CD
J Lipid Res; 2014 Dec; 55(12):2576-86. PubMed ID: 25278499
[TBL] [Abstract][Full Text] [Related]
18. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
[TBL] [Abstract][Full Text] [Related]
19. Aspirin eugenol ester attenuates oxidative injury of vascular endothelial cells by regulating NOS and Nrf2 signalling pathways.
Huang MZ; Yang YJ; Liu XW; Qin Z; Li JY
Br J Pharmacol; 2019 Apr; 176(7):906-918. PubMed ID: 30706438
[TBL] [Abstract][Full Text] [Related]
20. Increased bile acids in enterohepatic circulation by short-term calorie restriction in male mice.
Fu ZD; Klaassen CD
Toxicol Appl Pharmacol; 2013 Dec; 273(3):680-90. PubMed ID: 24183703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
